Markets:

Overview

News

Currencies

International

Treasuries

Aridis Pharmaceuticals Inc. - Common Stock (NQ:ARDS)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 18, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aridis Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

18 Stocks Moving in Monday's Pre-Market Session ↗

January 31, 2022

Gainers FGI Industries Ltd. (NASDAQ: FGI) rose 92.8% to $7.27 in pre-market trading after jumping 19% on Friday. The company, last week, priced its IPO at $6 per...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 28, 2022

Gainers Enveric Biosciences (NASDAQ:ENVB)...

Via Benzinga

How Is The Market Feeling About Aridis Pharmaceuticals Inc? ↗

January 28, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 28, 2022

Gainers Provention Bio (NASDAQ:PRVB) stoc...

Via Benzinga

Aridis Shares Rise On Funding For Inhaled Monoclonal Antibodies Against Influenza, COVID-19 ↗

January 27, 2022

The

Via Benzinga

33 Stocks Moving In Friday's Mid-Day Session ↗

January 28, 2022

Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 126% to $2.6219. Imperial Petroleum, last month, posted Q3 revenue of $4.1 million. Yoshitsu Co., Ltd (NASDAQ: TKLF...

Via Benzinga

(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest ↗

January 28, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

Looking Into Aridis Pharmaceuticals Inc's Recent Short Interest ↗

January 28, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

Peering Into Aridis Pharmaceuticals Inc's Recent Short Interest ↗

January 27, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

How Is The Market Feeling About Aridis Pharmaceuticals Inc? ↗

January 27, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

(ARDS) - Analyzing Aridis Pharmaceuticals Inc's Short Interest ↗

January 27, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

Looking Into Aridis Pharmaceuticals Inc's Recent Short Interest ↗

January 27, 2022

Aridis Pharmaceuticals Inc's (NASDAQ:ARDS) short percent of float has risen 3350.0% since last its last report. The company recently reported that it has 130.40 thousand shares...

Via Benzinga

Benzinga Pro's Top 5 Stocks To Watch For Thursday, Jan. 27, 2022: XLNX, ARDS, LRCX, HOOD, WDC ↗

January 27, 2022

Today's 5 Stock Ideas: Xilinx (XLNX) - Shares up premarket. The company reported Q3 earnings results. A Reuters report titled 'China conditionally approves AMD's $35...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 27, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) stock increased by 28.7% to $2.24 during Thursday's pre-market session. The company's market cap stands at $31.4...

Via Benzinga

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study ↗

January 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 27, 2022

Good morning, trader! We're starting off the day with an overview of the biggest pre-market stock movers to watch on Thursday!

Via InvestorPlace

41 Biggest Movers From Yesterday ↗

January 27, 2022

Gainers Ebang International Holdings Inc. (NASDAQ: EBON) shares gained 35.4% to settle at $1.09 on Wednesday as investors weighed the Federal Reserve Reserve decision to leave...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 26, 2022

Gainers Rani Therapeutics Hldgs (NASDAQ:RANI

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 25, 2022

Gainers Exterran Corporation (NYSE: EXTN) shares surged 59.7% to close at $4.79 on Monday after the company said it would merge with Enerflex to create a premier integrated...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 24, 2022

Gainers Aptorum Group (NASDAQ:APM) stock m...

Via Benzinga

11 Health Care Stocks Moving In Monday's Intraday Session ↗

January 24, 2022

Gainers Aridis Pharmaceuticals (NASDAQ:ARDS) shares rose 35.6% to $2.17 during Monday's regular session. The current volume of 5.6 million shares is 531.8% of Aridis...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 24, 2022

Gainers SAB Biotherapeutics (NASDAQ:SABS) stock moved upwards by 15.0% to $6.3 during Monday's pre-market session. The market value of their outstanding shares is at $...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 21, 2022

Gainers Mustang Bio (NASDAQ:MBIO) shares ...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 21, 2022

Good morning, investor! Let's close out the week right with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 20, 2022

Gainers Baudax Bio (NASDAQ:BXRX) stock rose 32.2% to $0.26 during Thursday's pre-market session. The company's market cap stands at $21.9 million. Aptorum Group (...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 13, 2022

Gainers Stealth BioTherapeutics (NASDAQ:MITO

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 12, 2022

Gainers Biomerica (NASDAQ:BMRA) stock inc...

Via Benzinga

63 Biggest Movers From Yesterday ↗

December 31, 2021

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Aridis Pharmaceuticals Inc. - Common Stock (NQ:ARDS)

Headline News about Aridis Pharmaceuticals Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today